Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities

Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities Publisher

Sarvizadeh M¹ ; Hasanpour O² ; Naderi Ghalenoie Z³ ; Mollazadeh S⁴ ; Rezaei M⁵ ; Pourghadamyari H⁶ ; Masoud Khooy M⁷ ; Aschner M⁸ ; Khan H⁹ ; Rezaei N^{10, 11, 12} ; Shojaie L¹³ ; Mirzaei H¹⁴

Source: Frontiers in Oncology Published:2021

Abstract

Digestive system cancer tumors are one of the major causes of cancer-related fatalities; the vast majority of them are colorectal or gastric malignancies. Epidemiological evidence confirmed that allium-containing food, such as garlic, reduces the risk of developing malignancies. Among all compounds in garlic, allicin has been most researched, as it contains sulfur and produces many second degradation compounds, such as sulfur dioxide, diallyl sulfide (DAS), diallyl trisulfide (DATS), and diallyl disulfide (DADS) in the presence of enzymatic reactions in gastric juice. These substances have shown anti-inflammatory, antidiabetic, antihypertensive, antifungal, antiviral, antibacterial, and anticancer efficacy, including gastrointestinal (GI) cancers, leukemia, and skin cancers. Herein, we summarize the therapeutic potential of allicin in the treatment of GI cancers. © Copyright © 2021 Sarvizadeh, Hasanpour, Naderi Ghale-Noie, Mollazadeh, Rezaei, Pourghadamyari, Masoud Khooy, Aschner, Khan, Rezaei, Shojaie and Mirzaei.

Related Docs

View other Related Docs

1. Bioactive Compounds and Biological Activities of Allium Sativum L., Reference Series in Phytochemistry (2024)

2. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer, Journal of Gastrointestinal Cancer (2017)

3. Pharmacological Properties of Allium Cepa, Preclinical and Clinical Evidences; a Review, Iranian Journal of Pharmaceutical Research (2021)

Experts (# of related papers)

View all Related Experts

Roja Rahimi (2)

Farzaneh Kianian (2)

Style	Citing Format
MLA	Sarvizadeh M, et al.. "Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities." Frontiers in Oncology, vol. 11, no. , 2021, pp. -.
APA	Sarvizadeh M, Hasanpour O, Naderi Ghalenoie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, Masoud Khooy M, Aschner M, Khan H, Rezaei N, Shojaie L, Mirzaei H (2021). Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities. Frontiers in Oncology, 11(), -.
Chicago	Sarvizadeh M, Hasanpour O, Naderi Ghalenoie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, Masoud Khooy M, et al.. "Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities." Frontiers in Oncology 11, no. (2021): -.
Harvard	Sarvizadeh M et al. (2021) 'Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities', Frontiers in Oncology, 11(), pp. -.
Vancouver	Sarvizadeh M, Hasanpour O, Naderi Ghalenoie Z, Mollazadeh S, Rezaei M, Pourghadamyari H, et al.. Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities. Frontiers in Oncology. 2021;11():-.
BibTex	@article{ author = {Sarvizadeh M and Hasanpour O and Naderi Ghalenoie Z and Mollazadeh S and Rezaei M and Pourghadamyari H and Masoud Khooy M and Aschner M and Khan H and Rezaei N and Shojaie L and Mirzaei H}, title = {Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities}, journal = {Frontiers in Oncology}, volume = {11}, number = {}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Sarvizadeh M AU - Hasanpour O AU - Naderi Ghalenoie Z AU - Mollazadeh S AU - Rezaei M AU - Pourghadamyari H AU - Masoud Khooy M AU - Aschner M AU - Khan H AU - Rezaei N AU - Shojaie L AU - Mirzaei H TI - Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities JO - Frontiers in Oncology VL - 11 IS - SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Abstract